Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-31 2025-03-31 true No description of principal activity 2025-02-28 false 49 38 true The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 12189197 2025-02-28 2025-03-31 12189197 2024-03-01 2025-02-27 12189197 2025-03-31 12189197 2025-02-27 12189197 2024-03-01 12189197 c:Director3 2025-02-28 2025-03-31 12189197 d:PlantMachinery 2025-02-28 2025-03-31 12189197 d:PlantMachinery 2025-03-31 12189197 d:PlantMachinery 2025-02-27 12189197 d:PlantMachinery d:OwnedOrFreeholdAssets 2025-02-28 2025-03-31 12189197 d:FurnitureFittings 2025-02-28 2025-03-31 12189197 d:FurnitureFittings 2025-03-31 12189197 d:FurnitureFittings 2025-02-27 12189197 d:FurnitureFittings d:OwnedOrFreeholdAssets 2025-02-28 2025-03-31 12189197 d:ComputerEquipment 2025-02-28 2025-03-31 12189197 d:ComputerEquipment 2025-03-31 12189197 d:ComputerEquipment 2025-02-27 12189197 d:ComputerEquipment d:OwnedOrFreeholdAssets 2025-02-28 2025-03-31 12189197 d:OtherPropertyPlantEquipment 2025-02-28 2025-03-31 12189197 d:OtherPropertyPlantEquipment 2025-03-31 12189197 d:OtherPropertyPlantEquipment 2025-02-27 12189197 d:OtherPropertyPlantEquipment d:OwnedOrFreeholdAssets 2025-02-28 2025-03-31 12189197 d:OwnedOrFreeholdAssets 2025-02-28 2025-03-31 12189197 d:CurrentFinancialInstruments 2025-03-31 12189197 d:CurrentFinancialInstruments 2025-02-27 12189197 d:Non-currentFinancialInstruments 2025-03-31 12189197 d:Non-currentFinancialInstruments 2025-02-27 12189197 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 12189197 d:CurrentFinancialInstruments d:WithinOneYear 2025-02-27 12189197 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 12189197 d:Non-currentFinancialInstruments d:AfterOneYear 2025-02-27 12189197 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-03-31 12189197 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-02-27 12189197 d:ShareCapital 2025-02-28 2025-03-31 12189197 d:ShareCapital 2025-03-31 12189197 d:ShareCapital 2024-03-01 2025-02-27 12189197 d:ShareCapital 2025-02-27 12189197 d:ShareCapital 2024-03-01 12189197 d:RetainedEarningsAccumulatedLosses 2025-02-28 2025-03-31 12189197 d:RetainedEarningsAccumulatedLosses 2025-03-31 12189197 d:RetainedEarningsAccumulatedLosses 2024-03-01 2025-02-27 12189197 d:RetainedEarningsAccumulatedLosses 2025-02-27 12189197 d:RetainedEarningsAccumulatedLosses 2024-03-01 12189197 c:FRS102 2025-02-28 2025-03-31 12189197 c:AuditExemptWithAccountantsReport 2025-02-28 2025-03-31 12189197 c:FullAccounts 2025-02-28 2025-03-31 12189197 c:PrivateLimitedCompanyLtd 2025-02-28 2025-03-31 12189197 2 2025-02-28 2025-03-31 12189197 e:PoundSterling 2025-02-28 2025-03-31 iso4217:GBP xbrli:pure

Registered number: 12189197 BM SPITALFIELDS LIMITED UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
BM SPITALFIELDS LIMITED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF BM SPITALFIELDS LIMITED FOR THE PERIOD ENDED 31 MARCH 2025 You consider that the Company is exempt from an audit for the period ended 31 March 2025. You have acknowledged, on the Balance sheet, your responsibilities for ensuring that the Company keeps adequate accounting records which comply with section 386 of the Companies Act 2006, and for preparing the financial statements which give a true and fair view of the state of affairs of the Company and of its profit or loss for the financial period. In accordance with your instructions, we have prepared the financial statements on pages 11 from the accounting records of the Company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these financial statements. Paperchase Business Services Ltd The Courtyard 14A Sydenham Road Croydon London CR0 2EE 18 March 2026 Page 1
BM SPITALFIELDS LIMITED REGISTERED NUMBER: 12189197 BALANCE SHEET AS AT 31 MARCH 2025
|  | 31 March |  | 27 February
|  | 2025 |  | 2025
Note |  | £ |  | £
Fixed assets |  |  |  |  |
Tangible assets | 4 |  | 67,273 |  | 64,951
|  |  | 67,273 |  | 64,951
Current assets |  |  |  |  |
Stocks |  | 17,265 |  | 17,496 |
Debtors: amounts falling due within one year | 5 | 2,123,242 |  | 2,301,406 |
Cash at bank and in hand | 6 | 81,752 |  | 50,921 |
|  | 2,222,259 |  | 2,369,823 |
Creditors: amounts falling due within one year | 7 | (1,834,625) |  | (2,087,762) |
Net current assets |  |  | 387,634 |  | 282,061
Total assets less current liabilities |  |  | 454,907 |  | 347,012
Creditors: amounts falling due after more than one year | 8 |  | (145,833) |  | (81,667)
Net assets |  |  | 309,074 |  | 265,345
Capital and reserves |  |  |  |  |
Called up share capital |  |  | 300 |  | 300
Profit and loss account |  |  | 308,774 |  | 265,045
|  |  | 309,074 |  | 265,345
The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements. The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities. The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime. The financial statements were approved and authorised for issue by the board and were signed on its behalf on Page 2
BM SPITALFIELDS LIMITED REGISTERED NUMBER: 12189197 BALANCE SHEET (CONTINUED) AS AT 31 MARCH 2025 18 March 2026.
................................................ Alexander Robert Large
Director
The notes on pages 5 to 11 form part of these financial statements. Page 3

|  | BM SPITALFIELDS LIMITED |
STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 31 MARCH 2025
|  | Called up share capital | Profit and loss account | Total equity
|  | £ | £ | £
| At 1 March 2024 | 300 | (45,087) | (44,787)
| Profit for the period | - | 310,132 | 310,132
| Total comprehensive income for the period | - | 310,132 | 310,132
| At 28 February 2025 | 300 | 265,045 | 265,345
| Profit for the period | - | 43,729 | 43,729
| Total comprehensive income for the period | - | 43,729 | 43,729
| At 31 March 2025 | 300 | 308,774 | 309,074
| The notes on pages 5 to 11 form part of these financial statements.
Page 4

BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
1. | General information
BM Spitalfields Limited is a private company limited by shares incorporated in England and Wales. The registered office address and company number are as below; Registered office : 81 Buckingham Palace Road, London, England, SW1W 0AJ. Company number : 12189197 2.Accounting policies
| 2.1 | Basis of preparation of financial statements
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view. These financial statements have been prepared for the one month period ended 31 March 2025. The accounting period has been shortened from the previous 12 month cycle in order to align the company’s accounting reference date with other group entities. As a consequence of the shortened reporting period, the comparative figures presented covering the 12 month period ended February 2025 are not directly comparable with the results for the current period. The following principal accounting policies have been applied: Page 5
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.2 | Revenue
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised: Sale of goods Revenue from the sale of goods is recognised when all of the following conditions are satisfied: ∙the Company has transferred the significant risks and rewards of ownership to the buyer; ∙the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the transaction; and ∙the costs incurred or to be incurred in respect of the transaction can be measured reliably. Rendering of services Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied: ∙the amount of revenue can be measured reliably; ∙it is probable that the Company will receive the consideration due under the contract; ∙the stage of completion of the contract at the end of the reporting period can be measured reliably; and ∙the costs incurred and the costs to complete the contract can be measured reliably.
| 2.3 | Operating leases: the Company as lessee
Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term. Benefits received and receivable as an incentive to sign an operating lease are recognised on a straight-line basis over the lease term, unless another systematic basis is representative of the time pattern of the lessee's benefit from the use of the leased asset.
| 2.4 | Interest income
Interest income is recognised in profit or loss using the effective interest method.
| 2.5 | Finance costs
Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument. Page 6
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.6 | Borrowing costs
All borrowing costs are recognised in profit or loss in the period in which they are incurred.
| 2.7 | Pensions
Defined contribution pension plan The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations. The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance sheet. The assets of the plan are held separately from the Company in independently administered funds.
| 2.8 | Tangible fixed assets
Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management. Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method. Depreciation is provided on the following basis:
|  |  |  | Plant and machinery | - | 25% | SLM
|  |  |  | Fixtures and fittings | - | 25% | SLM
|  |  |  | Computer equipment | - | 33% | SLM
|  |  |  | Improvement Building | - | 10% | SLM
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date. Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
| 2.9 | Stocks
Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads. At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss. Page 7
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025 2.Accounting policies (continued)
| 2.10 | Debtors
Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.
| 2.11 | Cash and cash equivalents
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
| 2.12 | Creditors
Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
3. | Employees
| The average monthly number of employees, including directors, during the period was 49 (2025 - 38).
Page 8
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
4. | Tangible fixed assets
|  | Plant and machinery | Fixtures and fittings | Computer equipment | Improvement Building | Total
|  | £ | £ | £ | £ | £
| Cost or valuation |  |  |  |  |
| At 28 February 2025 | 364,979 | 187,595 | 13,931 | 29,971 | 596,476
| Additions | 3,965 | - | - | - | 3,965
| At 31 March 2025 | 368,944 | 187,595 | 13,931 | 29,971 | 600,441
| Depreciation |  |  |  |  |
| At 28 February 2025 | 340,447 | 176,198 | 2,923 | 11,956 | 531,524
| Charge for the period on owned assets | 740 | 311 | 359 | 234 | 1,644
| At 31 March 2025 | 341,187 | 176,509 | 3,282 | 12,190 | 533,168
| Net book value |  |  |  |  |
| At 31 March 2025 | 27,757 | 11,086 | 10,649 | 17,781 | 67,273
| At 27 February 2025 | 24,532 | 11,396 | 11,008 | 18,015 | 64,951
5. | Debtors
|  |  |  |  | 31 March | 27 February
|  |  |  |  | 2025 | 2025
|  |  |  |  | £ | £
| Trade debtors | 1,732 | 1,169
| Other debtors | 2,036,085 | 2,194,573
| Prepayments and accrued income | 85,425 | 105,664
|  | 2,123,242 | 2,301,406
Page 9
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
6. | Cash and cash equivalents
|  |  |  |  | 31 March | 27 February
|  |  |  |  | 2025 | 2025
|  |  |  |  | £ | £
| Cash at bank and in hand | 81,752 | 50,921
|  | 81,752 | 50,921
7. | Creditors: Amounts falling due within one year
|  |  |  |  | 31 March | 27 February
|  |  |  |  | 2025 | 2025
|  |  |  |  | £ | £
| Bank loans | - | 70,000
| Trade creditors | 122,374 | 123,688
| Other taxation and social security | 788,610 | 713,009
| Other creditors | 894,442 | 1,154,858
| Accruals and deferred income | 29,199 | 26,207
|  | 1,834,625 | 2,087,762
8. | Creditors: Amounts falling due after more than one year
|  |  |  |  | 31 March | 27 February
|  |  |  |  | 2025 | 2025
|  |  |  |  | £ | £
| Bank loans | 145,833 | 81,667
|  | 145,833 | 81,667
Page 10
BM SPITALFIELDS LIMITED NOTES TO THE FINANCIAL STATEMENTS FOR THE PERIOD ENDED 31 MARCH 2025
9. | Loans
| Analysis of the maturity of loans is given below:
|  |  |  |  | 31 March | 27 February
|  |  |  |  | 2025 | 2025
|  |  |  |  | £ | £
| Amounts falling due within one year |  |
| Bank loans | - | 70,000
|  | - | 70,000
| Amounts falling due 1-2 years |  |
| Bank loans | 145,833 | 81,667
|  | 145,833 | 81,667
|  | 145,833 | 151,667
10. | Related party transactions
| At the year end the company owed £1,566,779 (Feb’25 £1,513,366) by BM Angel Limited, a related company, in respect of an interest free loan which is repayable on demand. At the year end the company owed £484 (Feb’25 £367,872) by Brother Marcus Limited, a related company, in respect of an interest free loan which is repayable on demand. At the year end the company owed £238,406 (Feb’25 £397,431) to BM Borough Limited, a related company, in respect of an interest free loan which is repayable on demand. At the year end the company owed £351,456 (Feb’25 £429,177) to BM South Kensington Limited, a related company, in respect of an interest free loan which is repayable on demand. At the year end the company owed £208,793 (Feb’25 £76,278) by BM Covent Garden Limited, a related company, in respect of an interest free loan which is repayable on demand. At the year end the company owed £3,694(Feb’25 £3,694) by BM Canary Wharf Limited, a related company, in respect of an interest free loan which is repayable on demand.
11. | Controlling party
The immediate and ultimate parent undertaking and controlling party is Brother Marcus Limited. The Company number is 09990976.
Page 11